Employment Verification for Rubius Therapeutics.

About Rubius Therapeutics

Rubius Therapeutics is a clinical-stage biopharmaceutical company that utilizes a proprietary RED PLATFORM™ to create a new class of cellular therapies for diverse diseases, including cancer, autoimmune disorders, and rare genetic diseases. The RED PLATFORM is designed to modulate the immune system by creating Red Cell Therapeutics™, or RCTs, which are engineered to have a range of therapeutic effects, including immune stimulation to target and eliminate tumor cells or viruses, as well as immune suppression to combat autoimmune diseases. The company’s lead product candidate, RTX-240, is aimed at targeting solid tumors and hematologic malignancies and is currently in Phase 1/2 clinical trials. Rubius Therapeutics is also developing therapies for the treatment of phenylketonuria, a rare genetic disorder, and sickle cell disease, among others. Rubius Therapeutics was founded in 2013 and is headquartered in Cambridge, Massachusetts. The company has partnerships with established pharmaceutical companies, including Eli Lilly and Company and Sanofi, and has been funded by prominent venture capital firms and investors, such as Flagship Pioneering, Fidelity Management & Research Company, and BlackRock, among others.

The information on this page is not an endorsement of Truv’s services by Rubius Therapeutics and is meant to be purely informational.

Verify Rubius Therapeutics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.